The role of serum SP-D is still debated, and the precise mechanisms linking SP-D to metabolic disturbances—particularly type 2 diabetes mellitus (T2DM)—have yet to be fully elucidated [31]. The gene discussed is SFTPD; the disease is diabetes mellitus.